Radiocobalt theranostic applications: current landscape, challenges, and future directions

Radiocobalt-based theranostics has emerged as a promising platform in nuclear medicine that offers dual capabilities for both diagnostic imaging and targeted radionuclide therapy. 55Co (t1/2 = 17.53 h, β+ = 77%, Eγ = 931.1 keV, Iγ = 75%) and 58mCo (t1/2 = 9.10 h, IC = 100%) serve as an elementally m...

תיאור מלא

מידע ביבליוגרפי

Principais autores:	Alexis M. Sanwick, Ivis F. Chaple
פורמט:	Artigo
שפה:	Inglês
יצא לאור:	Frontiers Media S.A. 2025-08-01
סדרה:	Frontiers in Nuclear Medicine
נושאים:	theranostics positron emission tomography targeted radionuclide therapy radiocobalt cobalt-55 cobalt-58m
גישה מקוונת:	https://www.frontiersin.org/articles/10.3389/fnume.2025.1663748/full
תגים:	הוספת תג אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!